Summary:
- This article discusses a lawsuit filed by the Federal Trade Commission (FTC) against Xlear, a company that makes nasal sprays, for making false and unsubstantiated claims about their products' ability to prevent or treat COVID-19.
- The FTC alleges that Xlear made misleading statements on its website and in social media posts, claiming that its nasal sprays could "kill" or "deactivate" the COVID-19 virus, despite lacking scientific evidence to support these claims.
- The lawsuit aims to stop Xlear from making these deceptive health claims and to provide refunds to consumers who purchased the products based on the company's misleading marketing.